Cary Street Partners Investment Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13	Closed	-$2.3K	–	679
2023 Q3	$2.3K	Hold	13	–	–	﹤0.01%	1637
2023 Q2	$2.47K	Hold	13	–	–	﹤0.01%	1560
2023 Q1	$2.6K	Hold	13	–	–	﹤0.01%	1462
2022 Q4	$3.09K	Buy	+13	New	+$3.09K	﹤0.01%	1430